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Abstract
Background: The study measured the accuracy of the Italian version of the Hypomania Checklist
(HCL-32) for self-assessment as a screening instrument for bipolar disorder (BPD) in a psychiatric
setting and compared results with a previous study, carried out in a comparable sample and in the
same setting, using the Mood Disorder Questionnaire (MDQ).
Methods: 123 consecutive subjects attending a psychiatric division were screened for BPD using
the Italian translation of the HCL-32, and diagnostically interviewed with the SCID by physicians.
The sample of the previous study using the MDQ consisted of 154 subjects.
Results: On the basis of the SCID: 26 received a diagnosis of bipolar/schizoaffective disorder, 57
were diagnosed as having at least another psychiatric disorder in Axis-I, whilst 40 were unaffected
by any type of psychiatric disorder. Comparing the bipolar with all other patients the HCL-32
showed a good accuracy: cut-off 8: sensitivity 0.92-specificity 0.48; cut-off 10: sensitivity 0.88-
specificity 0.54; cut-off 12: sensitivity 0.85-specificity 0.61. The accuracy for BPD-II (10) remains
good: cut-off 8: sensitivity 0.90-specificity 0.42; cut-off 10: sensitivity 0.80-specificity 0.47; cut-off
12: sensitivity 0.80-specificity 0.54. The comparison with the MDQ performance shows that both
screening tools may show good results, but HCL-32 seems to be more sensitive in detecting BPD-
II.
Conclusion: Our results seem to indicate good accuracy of HCL-32 as a screening instrument for
BPD in a psychiatric setting, with a low rate of false negatives, and a fairly good degree of
identification of BPD-II.
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Background
Bipolar disorder is a recurring psychiatric condition, of
chronic nature and highly invalidating. It is often under-
diagnosed, thus delaying the administration of efficient
treatments; it has been estimated that as many as one to
two thirds of individuals with bipolar disorder do not
receive appropriate treatment due to misdiagnosis [1].
Particularly hypomania as an element of bipolar-II disor-
der is very often not experienced and recognized by the
subject as pathological, therefore not reported to doctors
and under-diagnosed in 25 to 50% of depressive patients
[2].
Thus an easily administered screening instrument for self-
assessment may be useful in clinical practice, particularly
in settings in which a great number of medical patients are
referred for psychiatric screening before medical treat-
ments, such as interferon, hormone therapies with a bur-
den of risk for psychiatric disorders.
The aim of the present study, carried out in a sample of
psychiatric patients attending a mental health clinic, with
an elevated proportion of patients coming from the gen-
eral hospital for psychiatric evaluation, was to obtain a
preliminary standardization of one Italian version of the
HCL-32 as a screening instrument for bipolar disorders,
[2] and to compare results with a previous study, carried
out in a comparable sample and the same setting, using
the Mood Disorder Questionnaire (MDQ) [3]. The MDQ
is a internationally recognized screening instrument for
bipolar disorders [4-6] (Hirschfeld et al. 2000, 2003a,
2003b) that seems to be sensitive for identifying bipolar-
I disorders but probably less so for bipolar disorders-II
[7].
Methods
Study design
The study design consisted in the evaluation of the accu-
racy of one Italian version of HCL-32 [2], using the Struc-
tured Clinical Interview for DSM-IV Axis-I Disorders
(SCID) [8] as a gold standard. The results were compared
with the findings of a previous study, carried out in the
same setting and with the same methodology, in which
the Mood Disorder Questionnaire (MDQ) was applied.
The SCID was administered by physicians working in the
field of psychiatry for at least three years, all of whom had
undergone specific training for the use of the SCID.
Immediately prior to the interview all subjects had filled
in the Italian version of the HCL-32. Written informed
consent was obtained from all study participants. The
questionnaire had been translated into Italian before the
start of the research project, had been back-translated into
English, and approval had been obtained from one of the
authors of the original version.
Sample
A consecutive series of 123 subjects (41 males, mean age
36.6 ± 11.0 years; 81 females, mean age 37.9 ± 12.4 years)
referred to the Division of Psychiatry of the University of
Cagliari (Italy). The subjects were either (a) seeking psy-
chiatric care, (b) had been referred by a general medical
hospital for psychiatric evaluation before receiving medi-
cal treatments involving an elevated psychiatric risk
(interferon, hormone therapy, etc.), or (c) were applying
for legal certification of their mental capacities (for driv-
ing and/or gun licences, etc). The sample of the previous
study using the MDQ consisted of 154 subjects (61 males,
mean age 35.9 ± 12.3 years; 93 females, mean age 38.4 ±
12.5 years) also referred consecutively to the Division of
Psychiatry of the University of Cagliari (Italy).
Instruments
The Structured Clinical Interview for DSM-IV Disorders of
Axis-I [8] is a semi-structured interview aimed at formulat-
ing the main diagnoses covered by Axis-I of DSM-IV [9].
The HCL-32 is a self-administered paper and pencil inven-
tory made up of 32 yes/no items used to identify the
hypomanic component in patients with depressive epi-
sodes in order to help the clinician to diagnose bipolar-II
and minor bipolar disorders in psychiatric and general
medical practice [2]. In order to help diagnose hypomania
the instrument is designed to assess the personal and
social role consequences of hypomanic symptoms. It also
takes into account the subject's current overall affective
status (low – as usual – high) as a potentially interfering
variable in answering the questions. Several questions
also have the potential to reveal the extent to which the
patient has insight into his condition, which is important
for treatment considerations [2].
We evaluated the discriminatory capacity (patients with a
diagnosis of bipolar I or II disorder or schizoaffective
bipolar type versus patients with other psychiatric diag-
noses or with no psychiatric diagnosis, according to the
findings of the SCID) of all 32 items of the HCL-32. A spe-
cific evaluation concerning the accuracy in detecting bipo-
lar II disorders was also carried out.
The accuracy of the HCL-32 was calculated in terms of
sensitivity and specificity for each theoretically possible
cut-off point (number of positive answers). Overall per-
formance of the scale was graphically assessed by means
of the Receiver Operating Characteristic Analysis [10].Clinical Practice and Epidemiology in Mental Health 2006, 2:2 http://www.cpementalhealth.com/content/2/1/2
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Results
Table 1 shows the psychiatric diagnoses in Axis-I based on
the SCID. Of all subjects interviewed (total N = 123): 26
(21.14%) received a diagnosis of bipolar or schizoaffec-
tive bipolar disorder, 57 (58.76%) were diagnosed as hav-
ing at least one psychiatric disorder in Axis-I (other than
bipolar or schizoaffective), whilst 40 (41.24%) were unaf-
fected by any type of psychiatric disorder. Of the 26
patients identified as "bipolar cases" at the SCID interview
14 (53.8%) had bipolar I disorder, 10 (38.5%) had bipo-
lar II disorder and 2 (7.8%) schizoaffective bipolar disor-
der. Figure 1 illustrates the performance of the HCL-32 by
means of ROC analysis and reports for each cut-off sensi-
tivity and specificity, comparing the bipolar with all other
patients. Table 2 compares the best performing cut-off
scores of the HCL-32 for bipolar I and bipolar II disorder
with the results of the Mood Disorder Questionnaire
recently validated by our group in the same setting [3].
Discussion
The results of this study seem to indicate a fairly good per-
formance of the HCL-32, at least from a preliminary point
of view, in a specialist setting applying a traditional gold
standard (SCID diagnoses).
Results confirm the preliminary validation conducted on
an Italian and a Swedish sample where HCL-32 distin-
guished between bipolar and major depressive out-
patients. That result was based on the hypothesis that
DSM-IV criteria for hypomania are too strict [11]. For this
reason the previous study used a modified version of
SCID with its diagnoses as the gold standard.
Our study used a naturalistic sample of patients referred to
the Division of Psychiatry of the University of Cagliari
(Italy) for psychiatric treatment or legal certification. The
use of different cut-off points depends on the intended
use of the scale. For two-stage investigations (in which it
is important that "cases" are recognized during the screen-
ing phase because all positive cases will subsequently
undergo clinical assessment), it is necessary to reduce the
"false negatives" to a bare minimum. It is therefore prefer-
able to use a very high sensitivity, even though this may
prejudice the specificity. Cut-off point 4 of HCL-32 (sen-
sitivity 0.90, specificity 0.58) would for example allow an
accurate two-stage investigation to be carried out, whilst
reducing interviews by more than 50%. It should moreo-
ver be taken into account that epidemiologic studies are
performed in a specific setting (general population, gen-
eral practitioners) where the proportion of psychiatric dis-
orders is obviously lower than that observed in a clinical
sample recruited from a University Division of Psychiatry.
The latter would reasonably lead us to presume that the
screening instrument would perform better. For a one-
stage study in a general psychiatry setting the ideal cut-off
point could be 12 (sensitivity 0.85, specificity 0.61). The
latter is the nearest point to the 0.1 vertex of the ROC dia-
gram. Indeed, this point represents the ideal screener (sen-
sitivity 1, specificity 1). On the other hand, the area
depicted by the curve beyond the diagonal of the diagram
represents the area of validity of the screener. It should
moreover be underlined that the HCL-32 is a simple and
easy-to-use tool. The comparison with the MDQ perform-
ance shows that both screening tools may show good
results, but HCL-32 seems to be more sensitive in detect-
ing bipolar II disorders. Cut-offs with same sensitivity
Table 1: Psychiatric diagnoses in Axis-I formulated according to findings of the SCID semi-structured interview [8].
PSYCHIATRIC DIAGNOSES IN AXIS-I
Bipolar or Schizoaffective disorder At least another 1 disorder in Axis-I No diagnosis Total subjects
N%N%N%N
26 21.14 57 58.76 40 41.24 123
Table 2: Best performing cut-off of HCL-32 and MDQ for bipolar II disorders.
MDQ Cut-off MDQ sensitivity MDQ specificity HCL-32 Cut-off HCL-32 sensitivity HCL-32 specificity
Total Sample
4 0.90 0.56 8 0.92 0.48
5 0.84 0.70 10 0.88 0.54
6 0.76 0.86 12 0.85 0.61
Bipolar II disorders
4 0.80 0.45 8 0.90 0.42
5 0.70 0.55 10 0.80 0.47
6 0.55 0.65 12 0.80 0.54Clinical Practice and Epidemiology in Mental Health 2006, 2:2 http://www.cpementalhealth.com/content/2/1/2
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(0.80, at cut-off 4 for MDQ, and at cut-off 12 for HCL-32)
show a better specificity for HCL-32 (0.45 for MDQ, 0.54
for HCL-32); cut-offs showing the same specificity (cut-off
5 for MDQ = 0.55 and cut-off 12 HCL-32 = 0.54) have bet-
ter sensitivity for HCL-32 (0.80 versus 0.70).
An important problem is the recognition of bipolar-II dis-
orders in patients with major depressive episodes; thus
the HCL-32 for the self-assessment of hypomanic symp-
toms might be very helpful for identifying suspected and
manifest cases of bipolar disorders.
ROC analysis of the performance of the HCL-32 in the total sample Figure 1
ROC analysis of the performance of the HCL-32 in the total sample.
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Further studies are needed to verify the accuracy of this
tool in non-psychiatric settings and in the general popula-
tion.
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